Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline

Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment but are associated with significant autoimmune endocrinopathies that pose both diagnostic and treatment challenges. The aim of this guideline is to provide clinicians with the best possible evidence-based recommendations for tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Husebye, Eystein S, Castinetti, Frederik, Criseno, Sherwin, Curigliano, Giuseppe, Decallonne, Brigitte, Fleseriu, Maria, Higham, Claire E, Lupi, Isabella, Paschou, Stavroula A, Toth, Miklos, van der Kooij, Monique, Dekkers, Olaf M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Clinical Practice Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641795/
https://www.ncbi.nlm.nih.gov/pubmed/36149449
http://dx.doi.org/10.1530/EJE-22-0689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641795/
https://www.ncbi.nlm.nih.gov/pubmed/36149449
http://dx.doi.org/10.1530/EJE-22-0689

Ejemplares similares